Fethi Trabelsi

Fethi Trabelsi has a diverse work experience in the pharmaceutical industry, starting as a PK Scientist at MDS Pharma Services in 1998. Fethi then progressed to roles such as Director at Pharmanet/i3 Canada, Chief Scientific Officer at BioPharma Services Inc, Founder & Scientific Executive Advisor at Fact-Biopharma Solutions, and Head of Clinical Research and Medical Affairs at HEXO Corp. Fethi'smost recent role is as the VP Clinical Pharmacology at Allucent, showcasing their expertise in clinical development and strategic consulting.

Fethi Trabelsi holds a Doctor of Philosophy (PhD) in Exercise Physiology from Université de Montréal, completed between 1990-1995. Fethi also pursued a Post-doctoral Fellowship in Pharmacology and Physiology at the same university from 1995-1997. In 2017, they obtained a mini MBA from Schulich School of Business - York University, after completing a mini-MBA in Business/Commerce, General at York University in 2016.